On the occasion of the European Cervical Cancer Prevention Week, the European Institute of Women’s Health (EIWH), an EPHA member, presented its policy brief “Women and cervical cancer in the EU: promoting cervical cancer prevention” emphasising the need to reach a consensus across the European Union to put an end to the existing disparities between Member States.
With 31 300 women developing the disease and 13 600 dying of it every year in the EU, cervical cancer remains the second most common cancer in women under the age of 44. Caused by persistent infection with high-risk types of the Human Papilomavirus (HPV), the cervical cancer is uniquely preventable.
The incidence and mortality of cervical cancer has been constantly decreasing in Europe over the last decade, thanks to regular organised screening programs (which detect cell lesions before the cancer has the chance to develop) as well as vaccination (introduced in nineteen countries so far); however, there are great disparities in mortality across the EU, due to unequal access to prevention strategies. In 2003, the EU member states committed to implement cancer screening for early detection of breast, colon and cervical cancer but, in the 2008 Screening Report, it was revealed that some countries (mainly Eastern and Baltic State Members) were still lacking population based screening programs which was reflected in the highest mortality rates.
The European Institute of Women’s Health proposes in its brief the following steps for policy action:
- Revision of the Cervical Cancer Prevention Guidelines to integrate HPV vaccination and screening timetables for vaccinated women.
- Practical assistance for existing coalitions and networks supporting prevention and screening, particularly in Central and Eastern Europe and Baltic countries.
- Updating the European Code against Cancer to reflect current scientific progress in HPV vaccination.
- Reducing health inequalities by improving communication to young women, targeting specifically the disadvantaged or hard to reach ones.
- Evaluate the use of a single EU negotiation mechanism which makes HPV vaccination more affordable.
- Encourage a consensus on an efficient model for health technology assessment.
Given that a twin approach of screening and vaccination has the potential to reduce the cervical cancer burden over time, there is a need to develop a Cervical Prevention Strategy with a special focus and support for EU countries that are falling behind, so these massive disparities across Member States start to fade.
For more information:
———-
EPHA related articles:
- ->] [Roundtable: Promoting a Cervical Cancer Prevention Strategy for Europe- European Parliament (Brussels) 6 June 2012
- ->] [New WHO initiative to speed development and introduction of vaccines to protect against cervical cancer
- ->] [*Updated* European Union Action Against Cancer
- ->] [MEPs call for EU cancer task force
